SM

Snigdha Mohanty

Director Director DIN 03044269
DIN 03044269 First appointment May 2010 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2010
Shareholding value Locked Premium profile

About Snigdha Mohanty

Data last updated:

Snigdha Mohanty has 16 years in corporate governance. Formerly with 1 company, such as Charls Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 03044269
Primary Designation Director
First Appointment 08 May 2010
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Charls Biotech Private Limited U24290WB2010PTC147081
Director08 May 20102010Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Charls Biotech Private Limited
Premium access

Shareholding and investment profile for Snigdha Mohanty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Snigdha Mohanty

Snigdha Mohanty has 16 years in corporate governance. Formerly with 1 company, such as Charls Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Snigdha Mohanty is associated with 0 companies as a director.

Snigdha Mohanty has expertise in Technology.

Snigdha Mohanty has 16 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available